Evidence map›Paper›PMID 41381614›Full record

ArticleNature communications2025

Cohesin forms fountains at active enhancers in C. elegans.

Bolaji N Lüthi, Jennifer I Semple, Anja Haemmerli, Saurabh Thapliyal, Kalyan Ghadage, Klement Stojanovski, Dario D'Asaro, Moushumi Das, Nick Gilbert, Dominique A Glauser and 3 more

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. MIA-Jet: Multi-scale Identification Algorithm of Chromatin Jets.bioRxiv : the preprint server for biology · 2025
    Article
  10. Article
  11. Article
  12. Article
  13. The genome in space and time comes of age.Nucleus (Austin, Tex.) · 2024
    Article
  14. Transcriptional machinery as an architect of genome structure.Current opinion in structural biology · 2024
    Review
  15. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Bolaji N LüthiCell Fate and Nuclear Organization, Institute of Cell Biology, University of Bern, Bern, Switzerland.
Jennifer I SempleCell Fate and Nuclear Organization, Institute of Cell Biology, University of Bern, Bern, Switzerland.ORCID http://orcid.org/0000-0001-7221-9560
Anja HaemmerliCell Fate and Nuclear Organization, Institute of Cell Biology, University of Bern, Bern, Switzerland.
Saurabh ThapliyalDepartment of Biology, University of Fribourg, Fribourg, Switzerland.ORCID http://orcid.org/0000-0003-0363-4423
Kalyan GhadageCell Fate and Nuclear Organization, Institute of Cell Biology, University of Bern, Bern, Switzerland.
Klement StojanovskiOrganismal Systems Biology, Institute of Cell Biology, University of Bern, Bern, Switzerland.
Dario D'AsaroLaboratoire de Biologie et Modélisation de la Cellule, Ecole Normale Supérieure de Lyon, CNRS, UMR5239, Inserm U1293, Université Claude Bernard Lyon 1, Lyon, France.
Moushumi DasCell Fate and Nuclear Organization, Institute of Cell Biology, University of Bern, Bern, Switzerland.
Nick GilbertMedical Research Council Human Genetics Unit, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, UK.ORCID http://orcid.org/0000-0003-0505-6081
Dominique A GlauserDepartment of Biology, University of Fribourg, Fribourg, Switzerland.ORCID http://orcid.org/0000-0002-3228-7304
Benjamin TowbinOrganismal Systems Biology, Institute of Cell Biology, University of Bern, Bern, Switzerland.ORCID http://orcid.org/0000-0001-7046-1257
Daniel JostLaboratoire de Biologie et Modélisation de la Cellule, Ecole Normale Supérieure de Lyon, CNRS, UMR5239, Inserm U1293, Université Claude Bernard Lyon 1, Lyon, France.ORCID http://orcid.org/0000-0002-9877-6864
Peter MeisterCell Fate and Nuclear Organization, Institute of Cell Biology, University of Bern, Bern, Switzerland. peter.meister@unibe.ch.ORCID http://orcid.org/0000-0002-6230-4216

Funding

Enhancing and expanding the CGC Strain CollectionP40OD010440 · OD · UNIVERSITY OF MINNESOTA · PI Ann E. Rougvie · 2012 to 2026
$7.5M
NIH HHS P40 OD010440Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (Swiss National Science Foundation) 310030_212472Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (Swiss National Science Foundation) 31003A_176226Wellcome Trust
6 · The paper itself

Abstract

Transcriptional enhancers must locate target genes with precision. In mammals, topologically associating domains (TADs) guide this process, but the C. elegans genome lacks such organization despite containing over 30,000 putative enhancers. Using high-resolution Hi-C, we identify distinct 3D chromatin structures around active enhancers, termed fountains. These ~38 kb cohesin-dependent structures are unique to active enhancers and enriched for topoisomerases and negatively supercoiled DNA, indicating topological stress. Disrupting cohesin collapses fountains and leads to transcriptional upregulation of nearby genes, suggesting fountains act as spatial repressors controlling enhancer-promoter communication. This repression preferentially affects neuronal genes, including skn-1/Nrf, which changes isoform usage upon cohesin loss in ASI neurons. Cohesin cleavage also alters nematode movement and foraging behavior, linking 3D genome architecture to neural function and behavior. Thus, fountains represent a distinctive chromatin feature that may ensure enhancer specificity in a TAD-less genome.

Indexed as

Caenorhabditis elegansCaenorhabditis elegans ProteinsCell Cycle ProteinsChromosomal Proteins, Non-HistoneEnhancer Elements, GeneticAnimalsChromatinCohesinsNeuronsPromoter Regions, GeneticCaenorhabditis elegans ProteinsCell Cycle ProteinsChromatinChromosomal Proteins, Non-HistoneCohesins

Identifiers

PMID41381614
PMCPMC12820367

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.